Literature DB >> 27142121

DNA methylation and hypertension: emerging evidence and challenges.

Liyuan Han, Yanfen Liu, Shiwei Duan, Benjamin Perry, Wen Li, Yonghan He.   

Abstract

Hypertension is a multifactorial disease influenced by an interaction of environmental and genetic factors. The exact molecular mechanism of hypertension remains unknown. Aberrant DNA methylation is the most well-defined epigenetic modification that regulates gene transcription. However, studies on the association between DNA methylation and hypertension are still in their infancy. This review summarizes the latest evidence and challenges regarding the role of DNA methylation on hypertension.
© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  DNA methylation; environmental factor; epigenetics; gene expression; gene transcription; hypertension

Mesh：

Year:  2016        PMID： 27142121     DOI： 10.1093/bfgp/elw014

Source DB:  PubMed          Journal:  Brief Funct Genomics        ISSN： 2041-2649            Impact factor:   4.241


  12 in total

1.  The association between Alu hypomethylation and the severity of hypertension.

Authors:  Jirapan Thongsroy; Apiwat Mutirangura
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

Review 2.  DNA N6-Methyladenine Modification in Eukaryotic Genome.

Authors:  Hao Li; Ning Zhang; Yuechen Wang; Siyuan Xia; Yating Zhu; Chen Xing; Xuefeng Tian; Yinan Du
Journal:  Front Genet       Date:  2022-06-24       Impact factor: 4.772

3.  Predicting High Blood Pressure Using DNA Methylome-Based Machine Learning Models.

Authors:  Thi Mai Nguyen; Hoang Long Le; Kyu-Baek Hwang; Yun-Chul Hong; Jin Hee Kim
Journal:  Biomedicines       Date:  2022-06-14

Review 4.  New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis.

Authors:  Heng Li; Dan Wang; Yongjian Yuan; Jikang Min
Journal:  Arthritis Res Ther       Date:  2017-11-10       Impact factor: 5.156

5.  Methylenetetrahydrofolate reductase gene polymorphism, global DNA methylation and blood pressure: a population based study from North India.

Authors:  Suniti Yadav; Imnameren Longkumer; Shipra Joshi; Kallur Nava Saraswathy
Journal:  BMC Med Genomics       Date:  2021-02-27       Impact factor: 3.063

Review 6.  Preventive Aspects of Early Resveratrol Supplementation in Cardiovascular and Kidney Disease of Developmental Origins.

Authors:  Chien-Ning Hsu; Chih-Yao Hou; You-Lin Tain
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

Review 7.  Targeting the Renin-Angiotensin-Aldosterone System to Prevent Hypertension and Kidney Disease of Developmental Origins.

Authors:  Chien-Ning Hsu; You-Lin Tain
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

8.  DNA N6-methyladenine modification in hypertension.

Authors:  Ye Guo; Yuqing Pei; Kexin Li; Wei Cui; Donghong Zhang
Journal:  Aging (Albany NY)       Date:  2020-04-13       Impact factor: 5.682

9.  Metabolic profiling shows pre-existing mitochondrial dysfunction contributes to muscle loss in a model of ICU-acquired weakness.

Authors:  Paul R Kemp; Richard Paul; Aaron C Hinken; David Neil; Alan Russell; Mark J Griffiths
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-07-16       Impact factor: 12.910

Review 10.  Novel methylation mark and essential hypertension.

Authors:  Mayank Chaudhary
Journal:  J Genet Eng Biotechnol       Date:  2022-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.